دورية أكاديمية
3* * Italian multicenter phase III randomized study of cisplatin-etoposide with or without bevacizumab as first-line treatment in extensive stage small cell lung cancer (SCLC): GOIRC-AIFA FARM6PMFJM trial
| العنوان: | 3* * Italian multicenter phase III randomized study of cisplatin-etoposide with or without bevacizumab as first-line treatment in extensive stage small cell lung cancer (SCLC): GOIRC-AIFA FARM6PMFJM trial |
|---|---|
| المؤلفون: | Tiseo, M., Boni, L., Ambrosio, F., Camerini, A., Baldini, E., Cinieri, S., Zanelli, F., Defraia, E., Brighenti, M., Crinò, L., Dazzi, C., Tibaldi, C., Turolla, G.M., D'Alessandro, V., Zilembo, N., Trolese, A.R., Grossi, F., Riccardi, F., Ardizzoni, A. |
| بيانات النشر: | Oxford University Press |
| سنة النشر: | 2016 |
| المجموعة: | HighWire Press (Stanford University) |
| مصطلحات موضوعية: | Plenary Session |
| نوع الوثيقة: | text |
| وصف الملف: | text/html |
| اللغة: | English |
| العلاقة: | http://annonc.oxfordjournals.org/cgi/content/short/27/suppl_4/iv2Test; http://dx.doi.org/10.1093/annonc/mdw331.03Test |
| DOI: | 10.1093/annonc/mdw331.03 |
| الإتاحة: | https://doi.org/10.1093/annonc/mdw331.03Test http://annonc.oxfordjournals.org/cgi/content/short/27/suppl_4/iv2Test |
| حقوق: | Copyright (C) 2016, European Society for Medical Oncology |
| رقم الانضمام: | edsbas.F2231BC3 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1093/annonc/mdw331.03 |
|---|